atx 70 has been researched along with Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuroki, M; Shibaguchi, H; Tsuru, H; Yamashita, Y | 1 |
Asano, R; Hachimine, K; Kinugasa, T; Kuroki, M; Nakae, Y; Sakata, I; Shibaguchi, H; Shirakusa, T; Yamada, H; Yamashita, Y | 1 |
Nishigaki, R; Sasaki, K; Umemura, S; Yukawa, A; Yumita, N | 1 |
3 other study(ies) available for atx 70 and Neoplasms
Article | Year |
---|---|
Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Humans; Lipid Peroxidation; Malondialdehyde; Metalloporphyrins; Mice; Mice, SCID; Necrosis; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Sonication; Sound; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Sonodynamic therapy of cancer using a novel porphyrin derivative, DCPH-P-Na(I), which is devoid of photosensitivity.
Topics: Animals; Cell Line, Tumor; Humans; Mice; Mice, Inbred BALB C; Neoplasms; Photochemotherapy; Porphyrins; Reactive Oxygen Species; Spectrophotometry; Ultrasonics; Xenograft Model Antitumor Assays | 2007 |
Sonodynamically induced antitumor effect of gallium-porphyrin complex by focused ultrasound on experimental kidney tumor.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Kidney; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Porphyrins; Ultrasonic Therapy | 1997 |